Nature banner

Branching out.

Branching out from a parent company

You are here: Home / Insights / Case Studies


Pharmaceutical Company Establishes Stand-Alone Operation in the US.

Transitional Services Agreement | US Entity |  Carve Out


Our client is a pharmaceutical company that is branching out from its parent company during a recent carve out to focus on Research & Development for its groundbreaking medicine.


The company was supported by a Transitional Services Agreement (TSA) during the carve out and aimed to establish its own US operations as a standalone entity at the beginning of 2022. Unsure how to navigate this, the client called upon Amesto Global for assistance.


Amesto Global is delivering the following solution:

  • Assistance with transition services as the TSA comes to an end, set up opening balances in ERP system from TSA provider
  • Set up new ERP system, accounting operations, and supplemental accounting platforms and process workflows
  • Processing the day-to-day accounting on the client’s ERP system
  • Month-end closings which included all necessary GAAP adjustments
  • Preparation of a regular monthly financial reporting pack including an analysis of the financial performances (balance sheet, profit-and-loss and cash flow statement), budgets and forecasts, as well as “CFO” commentary on variances
  • Preparation of monthly board package with commentary for CEO presentation
  • Assist with monthly cash budget set by CEO and provide analysis and updates to stay with expected cash burn for the month
  • Assist with the coordination of tax return requests for R&D credits and year-end tax compliance
  • Complete coordination of services through a single point of contact

Ask More

Want to be our next Client Success Story?